This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Helmholtz Zentrum Muenchen—deutsches Forschungzentrum Fuer Gesundheit Un, Other. Active years: 2017-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2018
Title: Vishal Kalel: Innovator in Medicinal Chemistry
Introduction
Vishal Kalel is a prominent inventor based in Maharashtra, India. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on pyrazolopyridine derivatives. With a total of 2 patents to his name, Kalel's inventions are paving the way for new therapeutic options.
Latest Patents
Kalel's latest patents focus on pyrazolopyridine derivatives and their applications in therapy. These derivatives are recognized for their potential as medicaments, specifically in pharmaceutical compositions. His work emphasizes the use of these compounds in treating and preventing diseases caused by parasites of the family Trypanosomatidae. This research holds promise for developing effective treatments for various parasitic infections.
Career Highlights
Throughout his career, Vishal Kalel has worked with notable institutions, including Helmholtz Zentrum München—Deutsches Forschungzentrum für Gesundheit und Umwelt. His experience in these organizations has enriched his expertise in medicinal chemistry and innovation.
Collaborations
Kalel has collaborated with esteemed colleagues such as Michael Sattler and Grzegorz Popowicz. These partnerships have fostered a collaborative environment that enhances research and development in his field.
Conclusion
Vishal Kalel's contributions to medicinal chemistry through his innovative patents highlight his role as a key inventor in the industry. His work on pyrazolopyridine derivatives showcases the potential for new therapeutic advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile